-
3
-
-
4744366279
-
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
-
Tannock IF, Berry WR, Horti J et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004 351 : 1502 12
-
(2004)
N Engl J Med
, vol.351
, pp. 1502-12
-
-
Tannock, I.F.1
Berry, W.R.2
Horti, J.3
-
4
-
-
0031035693
-
Bcl2 is the guardian of microtubule integrity
-
Haldar S, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res 1997 57 : 229 33
-
(1997)
Cancer Res
, vol.57
, pp. 229-33
-
-
Haldar, S.1
Basu, A.2
Croce, C.M.3
-
5
-
-
2942625492
-
Preclinical pharmacology of the taxanes: Implications of the differences
-
Gligorov J, Lotz JP. Preclinical pharmacology of the taxanes: implications of the differences. Oncologist 2004 9 (Suppl. 2 3 8 (Pubitemid 38747838)
-
(2004)
Oncologist
, vol.9
, Issue.SUPPL. 2
, pp. 3-8
-
-
Gligorov, J.1
Lotz, J.P.2
-
6
-
-
33845650679
-
A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9
-
Sun LC, Luo J, Mackey LV, Fuselier JA, Coy DH. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Lett 2007 246 : 157 66
-
(2007)
Cancer Lett
, vol.246
, pp. 157-66
-
-
Sun, L.C.1
Luo, J.2
MacKey, L.V.3
Fuselier, J.A.4
Coy, D.H.5
-
7
-
-
0035985284
-
The clinical role of somatostatin analogues as antineoplastic agents: Much ado about nothing?
-
Hejna M, Schmidinger M, Raderer M. The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? Ann Oncol 2002 13 : 653 68
-
(2002)
Ann Oncol
, vol.13
, pp. 653-68
-
-
Hejna, M.1
Schmidinger, M.2
Raderer, M.3
-
8
-
-
0033561724
-
Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238
-
Plonowski A, Schally AV, Nagy A, Sun B, Szepeshazi K. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238. Cancer Res 1999 59 : 1947 53
-
(1999)
Cancer Res
, vol.59
, pp. 1947-53
-
-
Plonowski, A.1
Schally, A.V.2
Nagy, A.3
Sun, B.4
Szepeshazi, K.5
-
9
-
-
0036482860
-
Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238
-
Plonowski A, Schally AV, Nagy A, Sun B, Halmos G. Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238. Int J Oncol 2002 20 : 397 402
-
(2002)
Int J Oncol
, vol.20
, pp. 397-402
-
-
Plonowski, A.1
Schally, A.V.2
Nagy, A.3
Sun, B.4
Halmos, G.5
-
10
-
-
34447329624
-
Somatostatin effects on the proteome of the LNCaP cell-line
-
Liu Z, Bengtsson S, Krogh M et al. Somatostatin effects on the proteome of the LNCaP cell-line. Int J Oncol 2007 30 : 1173 9
-
(2007)
Int J Oncol
, vol.30
, pp. 1173-9
-
-
Liu, Z.1
Bengtsson, S.2
Krogh, M.3
-
11
-
-
0027364440
-
Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: Possible mechanism of action
-
Brevini TA, Bianchi R, Motta M. Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: possible mechanism of action. J Clin Endocrinol Metab 1993 77 : 626 31
-
(1993)
J Clin Endocrinol Metab
, vol.77
, pp. 626-31
-
-
Brevini, T.A.1
Bianchi, R.2
Motta, M.3
-
12
-
-
33644804885
-
Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis
-
Skjoth IH, Issinger OG. Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis. Int J Oncol 2006 28 : 217 29
-
(2006)
Int J Oncol
, vol.28
, pp. 217-29
-
-
Skjoth, I.H.1
Issinger, O.G.2
-
13
-
-
12344272623
-
Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells
-
DOI 10.1002/pros.20140
-
Fronsdal K, Saatcioglu F. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. Prostate 2005 62 : 299 306 (Pubitemid 40129069)
-
(2005)
Prostate
, vol.62
, Issue.3
, pp. 299-306
-
-
Fronsdal, K.1
Saatcioglu, F.2
-
14
-
-
0026604939
-
Basic fibroblast growth factor in human prostate cancer cells
-
Nakamoto T, Chang C, Li A. Basic fibroblast growth factor in human prostate cancer cells. Cancer Res 1992 52 : 571 7
-
(1992)
Cancer Res
, vol.52
, pp. 571-7
-
-
Nakamoto, T.1
Chang, C.2
Li, A.3
-
15
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984 22 : 27 55
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay, P.2
-
16
-
-
48749111500
-
The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: Experimental data
-
Lo NC, Maffi M, Fischel JL, Formento P, Milano G, Merlano M. The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: experimental data. BJU Int 2008 102 : 622 7
-
(2008)
BJU Int
, vol.102
, pp. 622-7
-
-
Lo, N.C.1
Maffi, M.2
Fischel, J.L.3
Formento, P.4
Milano, G.5
Merlano, M.6
-
17
-
-
0025996354
-
Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones
-
Schuurmans AL, Bolt J, Veldscholte J, Mulder E. Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 1991 40 : 193 7
-
(1991)
J Steroid Biochem Mol Biol
, vol.40
, pp. 193-7
-
-
Schuurmans, A.L.1
Bolt, J.2
Veldscholte, J.3
Mulder, E.4
-
18
-
-
0027730415
-
Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines
-
Ching KZ, Ramsey E, Pettigrew N, D'Cunha R, Jason M, Dodd JG. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 1993 126 : 151 8
-
(1993)
Mol Cell Biochem
, vol.126
, pp. 151-8
-
-
Ching, K.Z.1
Ramsey, E.2
Pettigrew, N.3
D'Cunha, R.4
Jason, M.5
Dodd, J.G.6
-
19
-
-
39449103998
-
TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells
-
Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Prostate 2008 68 : 287 95
-
(2008)
Prostate
, vol.68
, pp. 287-95
-
-
Zhu, M.L.1
Partin, J.V.2
Bruckheimer, E.M.3
Strup, S.E.4
Kyprianou, N.5
-
20
-
-
35648999534
-
Recent advances in cancer stem/progenitor cell research: Therapeutic implications for overcoming resistance to the most aggressive cancers: Stem Cells Review Series
-
DOI 10.1111/j.1582-4934.2007.00088.x
-
Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 2007 11 : 981 1011 (Pubitemid 350037046)
-
(2007)
Journal of Cellular and Molecular Medicine
, vol.11
, Issue.5
, pp. 981-1011
-
-
Mimeault, M.1
Hauke, R.2
Mehta, P.P.3
Batra, S.K.4
-
21
-
-
0033304745
-
Transforming growth factor-beta1-induced proliferation of the prostate cancer cell line, TSU-Pr1: The role of platelet-derived growth factor
-
Sintich SM, Lamm ML, Sensibar JA, Lee C. Transforming growth factor-beta1-induced proliferation of the prostate cancer cell line, TSU-Pr1: the role of platelet-derived growth factor. Endocrinology 1999 140 : 3411 5
-
(1999)
Endocrinology
, vol.140
, pp. 3411-5
-
-
Sintich, S.M.1
Lamm, M.L.2
Sensibar, J.A.3
Lee, C.4
-
22
-
-
11244303506
-
Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors
-
Singer CF, Hudelist G, Lamm W, Mueller R, Czerwenka K, Kubista E. Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors. Endocr Relat Cancer 2004 11 : 861 9
-
(2004)
Endocr Relat Cancer
, vol.11
, pp. 861-9
-
-
Singer, C.F.1
Hudelist, G.2
Lamm, W.3
Mueller, R.4
Czerwenka, K.5
Kubista, E.6
-
23
-
-
0033152596
-
Transforming growth factor-beta in benign and malignant prostate
-
Lee C, Sintich SM, Mathews EP et al. Transforming growth factor-beta in benign and malignant prostate. Prostate 1999 39 : 285 90
-
(1999)
Prostate
, vol.39
, pp. 285-90
-
-
Lee, C.1
Sintich, S.M.2
Mathews, E.P.3
|